Oral Rapamycin After Coronary Bare-Metal Stent Implantation to Prevent Restenosis

The purpose of this study was to assess the role of oral rapamycin in decreased restenosis after bare metal stent implantation. Small observational studies suggest that the administration of oral rapamycin reduces angiographic restenosis after bare metal stent implantation. Between September 2003 and September 2004, 100 patients were randomized to either oral rapamycin (6-mg loading dose given 2.7 h before intervention followed by 3 mg/day for...